Publication | Closed Access
Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418
22
Citations
42
References
2016
Year
Medicinal ChemistryOxysterolAldehyde DehydrogenaseBiochemistryNatural SciencesMedicineMechanism Of ActionMichael Acceptor5-Lipoxygenase InhibitorSurface Cysteines C416Drug DevelopmentChemical BiologyPharmacologyPharmaceutical ChemistryDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1